University Of Notre Dame Du Lac Madrigal Pharmaceuticals, Inc. Transaction History

University Of Notre Dame Du Lac

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $731,721 - $1.53 Million	-12,169 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $166,299 - $232,883	2,491 Added 25.74%	12,169 $812,000
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $18,373 - $25,833	-218 Reduced 2.2%	9,678 $882,000
Q3 2019 Nov 13, 2019	SELL	$84.4 - $106.53 $2.1 Million - $2.65 Million	-24,840 Reduced 71.51%	9,896 $853,000
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $1.41 Million - $2.2 Million	15,463 Added 80.23%	34,736 $3.64 Million
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $18,005 - $25,028	174 Added 0.91%	19,273 $2.41 Million
Q4 2018 Feb 13, 2019	BUY	$94.77 - $215.54 $698,170 - $1.59 Million	7,367 Added 62.79%	19,099 $2.15 Million
Q3 2018 Nov 13, 2018	BUY	$207.3 - $300.31 $2.43 Million - $3.52 Million	11,732 New	11,732 $2.51 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.